PHARMTRENDS

Serial Number 75255714
Registration 2256298
710

Registration Progress

Application Filed
Mar 11, 1997
Under Examination
Approved for Publication
Mar 5, 1999
Published for Opposition
Apr 6, 1999
Registered
Jun 29, 1999

Trademark Image

PHARMTRENDS

Basic Information

Serial Number
75255714
Registration Number
2256298
Filing Date
March 11, 1997
Registration Date
June 29, 1999
Published for Opposition
April 6, 1999
Cancellation Date
January 31, 2010
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Jan 31, 2010

Rights Holder

IPSOS-INSIGHT, INC.

03
Address
100 CHARLES LINDBERGH BLVD.
UNIONDALE, NY 11553

Ownership History

NPD GROUP, INC., THE

Original Applicant
03
Port Washington, NY

NPD GROUP, INC., THE

Owner at Publication
03
Port Washington, NY

NPD GROUP, INC., THE

Original Registrant
03
Port Washington, NY

IPSOS-INSIGHT, INC.

New Owner After Registration #1
03
UNIONDALE, NY

Legal Representation

Attorney
RUTH L LANSNER

USPTO Deadlines

Next Deadline
1331 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 1999-06-29)
Due Date
June 29, 2029
Grace Period Ends
December 29, 2029

Application History

13 events
Date Code Type Description Documents
Jan 31, 2010 CAEX O CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 Loading...
Mar 5, 2005 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Nov 18, 2004 MAIL I PAPER RECEIVED Loading...
Nov 18, 2004 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Jun 29, 1999 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 6, 1999 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 5, 1999 NPUB O NOTICE OF PUBLICATION Loading...
Dec 11, 1998 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 20, 1998 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 29, 1998 CNRT F NON-FINAL ACTION MAILED Loading...
Aug 25, 1997 CNRT F NON-FINAL ACTION MAILED Loading...
Aug 15, 1997 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 8, 1997 DOCK D ASSIGNED TO EXAMINER Loading...

Additional Information

Pseudo Mark
PHARM TRENDS